ABSTRACT GUIDELINES & FORM

The scientific committee is delighted to receive your abstracts for the 5th International Conference on Hemophilia and Rare Bleeding Disorder| 10-11 October 2025 | Grand Hyatt Hotel, Abu Dhabi, UAE.

DEADLINE OF SUBMISSION: AUG 20, 2026 (23:59 UAE/GST)

NOTIFICATION OF ACCEPTED ABSTRACTS: SEP 01, 2026

AUTHOR & ABSTRACT INFORMATION

• A maximum of 2 abstracts may be submitted.
• For abstracts with several authors, you must choose one individual to present the abstract at the conference.
• The abstracts must:
  • provide enough information for reviewers to assess the topic's nature and significance, the suitability of the investigative technique, the nature of the results, and the conclusions.
  • summarize the work's substantive outcomes rather than simply listing subjects to be explored.
  • be original scientific data gathered by the author(s) must be included in the abstract. All reports must be based on previously completed work. No "in progress" studies will be allowed.
  • include enough information for reviewers to determine the nature and significance of the topic, the sufficiency of the investigation technique, the nature of the results, and the conclusions, according to the criteria
• The primary author/first author/presenting author will receive:
  • complimentary registration for all days of the conference and
  • a certificate of attendance and appreciation for your presentation
• The presenter must NOT utilize the session to promote services, products, or other entities that are commercial in nature.
• Travel and lodging expenses will be shouldered by presenter.